Vision Institute of Colorado
  • Home
  • Vision Care
    • Vision Care Overview
    • Eye Exams
    • Contact Lens Exams
    • Diabetic Eye Exam
    • Dry Eye Treatments
    • Surgery >
      • Laser Cataract
      • Premium Lens Implants
      • Glaucoma
      • Eyelid Surgeries
    • Education >
      • Cataracts
      • Macular Degeneration
      • Presbyopia
    • Research
    • Eyecare Emergencies
  • Doctors
    • Our Doctors
    • Dr. Simmons
    • Dr. Anderson
    • Dr. Henderson
    • Ophthalmology
    • Optometry
  • Patients
    • Patient Forms
    • Insurance & Billing
  • Optical Shop
    • Retail Shop
    • Prescription Eyeglasses
    • Contact Lenses
    • Progressive Lenses
    • Computer Glasses
  • Contact
    • Appointments
    • University Village
  • Vision News
  • Patient Portal
    • PAY YOUR BILL ONLINE

Vision Research And Clinical Trials


Eye Care and Vision Research

eye clinical trialsresearch@vicolorado.com
​Vision Institute is dedicated to conducting high-quality clinical trials as a way to discover new treatment alternatives. Our four clinicians specialize in the diagnosis and treatment of sight threatening diseases such as glaucoma, cataracts, and macular degeneration. Our doctors have numerous years of research history.

Our commitment is to our patients and patient care.  The opportunity to participate in clinical trials allows us to discover new treatment options and access cutting edge technology.

​Although some may think that research is done in a lab by a scientist that is not an accurate perception of clinical trials and the need for patient participation. Your participation is required in order for clinical trials to be conducted allowing introduction of new drugs and treatment options. Vision Institute takes great pride in efficiently conducting trials in an ethical, harmless, and efficient method to protect patient’s rights during the clinical process.

Research Department Staff
Blake Simmons, O.D. FAAO - Erik Anderson, MD -        
Helene Agbo – clinical research coordinator 

Active & Upcoming Studies

May 2019-Present: “A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap 0.25% Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease”. (Ongoing, Recruitment closed)
 
May 2019-Present: Ophthalmic assessments of Signs and Symptoms of Dry eye in Patients Suffering from Self-Reported or Clinician-Diagnosed Dry Eye Disease.
The purpose of this study is to evaluate your eyes in order to determine the severity of your Dry Eye signs and symptoms. (Currently recruiting)
 
Future Studies
New Studies Coming Soon for the following indications: Dry Eye Disease and Allergic Conjunctivitis.
​
We are constantly looking for and starting new studies for various eye conditions, please contact our clinical research department at 719-559-2020 Ext#116 for information about our current opportunities.
 

Closed and Completed Studies

2017 A Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients with a Chalazion

2017 The objective of this study is to assess the safety and efficacy of RGN-259 Ophthalmic Solution compared to placebo for the treatment of Neurotrophic Keratitis

2017               A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of RGN-259 Ophthalmic Solutions for the Treatment of Dry Eye: ARISE-2 

2017               A prospective, targeted, non-interventional (observation) study of subjects who developed corneal deposits in clinical trials – Vision Institute, Colorado Springs, CO Aerie Pharmaceuticals Phase III–Glaucoma/Cornea Study (not recruiting)
​
2016                A prospective, double-masked, randomized, multi-center, active-controlled, parallel-group, 3-month study assessing the safety and ocular hypotensive efficacy of PG324 Ophthalmic Solution compared to AR-13324 Ophthalmic Solution, 0.02% and latanoprost Ophthalmic Solution, 0.005% in subjects with elevated intraocular pressure – Vision Institute, Colorado Springs, CO Aerie Pharmaceuticals Phase III–Glaucoma

2015 This study will evaluate a new ophthalmic formulation of cyclosporine in patients with moderate to severe dry eye disease in two stages.– Vision Institute, Colorado Springs, CO  Allergan Phase II–Dry Eye Study

2015                A Randomized, Double-masked, Vehicle-controlled Study of LME636 in the Relief of Persistent Ocular Discomfort in Patients With Severe Dry Eye Disease– Vision Institute, Colorado Springs, CO Phase II–Dry Eye Study

2014-2015       Evaluation of the ocular hypotensive efficacy and safety of Netarsudil (AR-13324) Ophthalmic Solution compared to Timolol Maleate Ophthalmic Solution– Vision Institute, Colorado Springs, CO  Aerie Pharmaceuticals Phase III–Glaucoma Study

2011-2012       A Phase 3 Multicenter, Randomized, Controlled, Double-Masked Study of Safety and Efficacy of Sodium Hyaluronate Ophthalmic Solution, 0.18% in Dry Eye Syndrome– St. Luke’s Eye Care & Laser Center, Colorado Springs, CO   Alcon–Dry Eye Study

2009                The purpose of this study is to determine whether AL-38583 ophthalmic solution is effective for treatment of signs and symptoms of dry eye.– St. Luke’s Eye Care & Laser Center, Colorado Springs, CO   Alcon Phase II –Dry Eye Study

2009                Examination of Ocular Surface Effects With Administration of TRAVATAN Z® and XALATAN®– St. Luke’s Eye Care & Laser Center, Colorado Springs, CO   Alcon Phase 4 –Ocular Surface Effect

2009                Alcon C-08-034 -Dry Eye Study– St. Luke’s Eye Care & Laser Center, Colorado Spring, CO

2008-2009       Alcon C-07-015 –Dry Eye Study – St. Luke’s Eye Care & Laser Center, Colorado Springs, CO

2007                A Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates– St. Luke’s Eye Care & Laser Center, Colorado Springs, CO   Alcon C-05-04 Phase II –Corneal Infiltrate Study    

2007                A double masked study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.– St. Luke’s Eye Care & Laser Center, Colorado Springs, CO Alcon C-05-31 Phase II B –Dry Eye Study

1998                Allergan Phase II –Cyclosporine A – St. Luke’s Eye Care & Laser Center, Colorado Springs, CO

1996-1997       Pharmacia Phase III –Latanoprost – St. Luke’s Eye Care & Laser Center, Colorado Springs, CO

1993                 Research –Effects of Cigarette Smoking on Results of Automated Standard Perimetry 

​Clinical Trials
(Visit www.ClinicalTrials.gov for additional detail)

New Studies Coming Soon for the following indications: Glaucoma, Cataracts, Chalazion, Neurotrophic Keratitis, and Dry eye syndrome
​
We are constantly looking for and starting new studies for various eye conditions, please contact our clinical research department at 719-559-2020 Ext#116 for information about our current opportunities.

Participant Application For Open Vision Clinical Trials

We are constantly looking for and starting new studies for various eye conditions, please contact our clinical research department at 719-559-2020 Ext#116 for information about our current opportunities.

If you feel you are a good candidate and are interested in participating in a clinical trial please fill out the participant application.

​Participant Application
    Summarize your previous clinical trial experience.
    Thank you for completing this application form and for your interest in research. The research coordinator will contact you for future actions. Research email: research@vicolorado.com.
Submit
Picture
Vision Institute Central 
​320 East Fontanero  #201
​Colorado Springs, CO 80907
Phone: (719) 559-2020
Fax: (719) 632-6088


​Downtown Office Hours 

Monday 8:00 AM - 5:00 PM

Tuesday 8:00 AM - 5:00 PM
Wednesday 8:00 AM - 5:00 PM
Thursday 8:00 AM - 5:00 PM
Friday 8:00 AM - 5:00 PM
Saturday Closed

Sunday Closed
Vision Institute North
5278 N Nevada Ave  #120
​Colorado Springs, CO 80918

Phone: 
(719) 471-4000

Fax: (719) 632-6088​


​Vision Institute North Office Hours 
Monday 8:00 AM - 5:00 PM
Tuesday 8:00 AM - 5:00 PM
Wednesday 8:00 AM - 5:00 PM
Thursday 8:00 AM - 5:00 PM
Friday 8:00 AM - 5:00 PM
Saturday: 9:00 AM - 5:00 PM
Sunday Closed

 Copyright 2019 Vision Institute Colorado Springs, CO
HTML Sitemap
XML Sitemap
Dear Vision Institute Friends and Family,
Since the coronavirus outbreak began weeks ago, we have followed the news and the best practices recommended by the CDC and other government agencies.  Vision Institute’s highest priority is the safety and health of our patients and employees.  Our daily protocols for cleaning and disinfecting our offices have always been a high priority and 5-star standard.  With the combination of peak flu season and growing concerns about coronavirus, we are now even more diligent.
Our Procedures to Protect Against Coronavirus
  • Home
  • Vision Care
    • Vision Care Overview
    • Eye Exams
    • Contact Lens Exams
    • Diabetic Eye Exam
    • Dry Eye Treatments
    • Surgery >
      • Laser Cataract
      • Premium Lens Implants
      • Glaucoma
      • Eyelid Surgeries
    • Education >
      • Cataracts
      • Macular Degeneration
      • Presbyopia
    • Research
    • Eyecare Emergencies
  • Doctors
    • Our Doctors
    • Dr. Simmons
    • Dr. Anderson
    • Dr. Henderson
    • Ophthalmology
    • Optometry
  • Patients
    • Patient Forms
    • Insurance & Billing
  • Optical Shop
    • Retail Shop
    • Prescription Eyeglasses
    • Contact Lenses
    • Progressive Lenses
    • Computer Glasses
  • Contact
    • Appointments
    • University Village
  • Vision News
  • Patient Portal
    • PAY YOUR BILL ONLINE